Valvular heart disease as a possible predictor of trastuzumab-induced cardiotoxicity in patients with breast cancer

Although the use of trastuzumab has been reported to improve overall survival in patients with HER2-positive breast cancer, there is increasing concern about the adverse effects of trastuzumab-induced cardiotoxicity (TIC). The aim of the present study was to investigate the predictor of TIC and to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Akihiko, Yoshihisa, Akiomi, Miyata-Tatsumi, Makiko, Oikawa, Masayoshi, Kobayashi, Atsushi, Ishida, Takafumi, Ohtake, Tohru, Takeishi, Yasuchika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313940/
https://www.ncbi.nlm.nih.gov/pubmed/30655975
http://dx.doi.org/10.3892/mco.2018.1764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313940/
https://www.ncbi.nlm.nih.gov/pubmed/30655975
http://dx.doi.org/10.3892/mco.2018.1764

Ejemplares similares